Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
Dec 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within
-
Application Deadline 11 Dec 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff
-
Deadline 17 Nov 2025 - 00:00 (UTC) Type of Contract Other Job Status Part-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position
-
Deadline 11 Nov 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position
-
(R3) Country United Kingdom Application Deadline 29 Sep 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
positive difference to local and global health. You will receive support and line management from the Programme Manager. The skills/experience needed RCCP/AHCS/ARTP/SCST registration Teaching experience
-
Researcher (R3) Country United Kingdom Application Deadline 12 Jan 2026 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a
-
qualifications and / or experience in a relevant discipline by the start of the appointment. For informal enquiries about the position or research programme, please contact Dr João M. Mendonça (Astronomy Research
-
United Kingdom Application Deadline 15 Dec 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job
-
the laboratory of Professors Ward and Ober. Their interdisciplinary research program is dedicated to the development of novel antibody-based therapeutics that has led to several therapeutics that are currently in